JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 114 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $149 | +67.4% | 80,336 | 0.0% | 0.00% | – |
| Q4 2022 | $89 | -99.9% | 80,336 | +104.2% | 0.00% | – |
| Q3 2022 | $93,000 | +57.6% | 39,336 | +100.5% | 0.00% | – |
| Q2 2022 | $59,000 | -86.5% | 19,618 | -69.5% | 0.00% | – |
| Q1 2022 | $437,000 | +414.1% | 64,309 | +530.9% | 0.00% | – |
| Q4 2021 | $85,000 | -94.3% | 10,194 | -94.9% | 0.00% | – |
| Q3 2021 | $1,497,000 | +18.4% | 201,494 | +8.4% | 0.00% | – |
| Q2 2021 | $1,264,000 | -12.5% | 185,858 | +32.2% | 0.00% | – |
| Q1 2021 | $1,444,000 | +96.5% | 140,626 | +33.9% | 0.00% | – |
| Q4 2020 | $735,000 | – | 104,996 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |